Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Peptides ; 95: 76-83, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28764966

ABSTRACT

Human rhinoviruses (HRVs) are the most common cause of viral respiratory tract infections, and are associated with significant morbidity and mortality in immunocompromised individuals and patients with pre-existing pulmonary conditions. The therapeutic options available are extremely limited and therefore novel therapeutics for HRV infections are of significant interest. Cathelicidins have been shown to have potent antiviral activity against a range of pathogens and are known to be key immunomodulatory mediators during infection. We therefore assessed the antiviral potential of cathelicidins from humans and other mammalian species against HRV, together with the potential for the human cathelicidin to modulate apoptotic pathways and alter cell viability during HRV infection. We demonstrate that LL-37, the porcine cathelicidin Protegrin-1, and the ovine cathelicidin SMAP-29 display potent antiviral activity towards HRV and that this activity is visible when either the virus is exposed to the peptides prior to cell infection or after cells have been infected. We further demonstrate that, in contrast to established findings with bacterial infection models, LL-37 does not induce apoptosis or necrosis in HRV-infected lung epithelial cells at physiological or superphysiological concentrations, but does reduce the metabolic activity of infected cells compared to uninfected cells treated with similar peptide concentrations. Collectively, the findings from this study demonstrate that the mechanism of action of cathelicidins against rhinovirus is by directly affecting the virus and we propose that the delivery of exogenous cathelicidins, or novel synthetic analogues, represent an exciting and novel therapeutic strategy for rhinovirus infection.


Subject(s)
Antimicrobial Cationic Peptides/pharmacology , Cathelicidins/pharmacology , Respiratory Tract Infections/drug therapy , Rhinovirus/drug effects , Animals , Antimicrobial Cationic Peptides/therapeutic use , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , Blood Proteins/pharmacology , Blood Proteins/therapeutic use , Cathelicidins/genetics , Cathelicidins/therapeutic use , Epithelial Cells/drug effects , Epithelial Cells/virology , Humans , Respiratory Tract Infections/genetics , Respiratory Tract Infections/virology , Rhinovirus/pathogenicity , Sheep , Swine
2.
J Immunol ; 199(7): 2483-2490, 2017 10 01.
Article in English | MEDLINE | ID: mdl-28814602

ABSTRACT

Host defense peptides, also known as antimicrobial peptides, are key elements of innate host defense. One host defense peptide with well-characterized antimicrobial activity is the human cathelicidin, LL-37. LL-37 has been shown to be upregulated at sites of infection and inflammation and is regarded as one of the primary innate defense molecules against bacterial and viral infection. Human exposure to combustion-derived or engineered nanoparticles is of increasing concern, and the implications of nanomaterial exposure on the human immune response is poorly understood. However, it is widely acknowledged that nanoparticles can interact strongly with several immune proteins of biological significance, with these interactions resulting in structural and functional changes of the proteins involved. This study investigated whether the potent antibacterial and antiviral functions of LL-37 were inhibited by exposure to, and interaction with, carbon nanoparticles, together with characterizing the nature of the interaction. LL-37 was exposed to carbon black nanoparticles in vitro, and the antibacterial and antiviral functions of the peptide were subsequently assessed. We demonstrate a substantial loss of antimicrobial function when the peptide was exposed to low concentrations of nanomaterials, and we further show that the nanomaterial-peptide interaction resulted in a significant change in the structure of the peptide. The human health implications of these findings are significant, as, to our knowledge, this is the first evidence that nanoparticles can alter host defense peptide structure and function, indicating a new role for nanoparticle exposure in increased disease susceptibility.


Subject(s)
Antimicrobial Cationic Peptides/chemistry , Antimicrobial Cationic Peptides/metabolism , Carbon , Nanoparticles/chemistry , Nanoparticles/toxicity , Anti-Bacterial Agents/pharmacology , Antimicrobial Cationic Peptides/pharmacology , Antiviral Agents/pharmacology , Bacteria/drug effects , Humans , Inflammation , Rhinovirus/drug effects , Cathelicidins
3.
Pathog Glob Health ; 110(4-5): 137-47, 2016.
Article in English | MEDLINE | ID: mdl-27315342

ABSTRACT

Cationic Host Defense Peptides (HDP, also known as antimicrobial peptides) are crucial components of the innate immune system and possess broad-spectrum antibacterial, antiviral, and immunomodulatory activities. They can contribute to the rapid clearance of biological agents through direct killing of the organisms, inhibition of pro-inflammatory mediators such as lipopolysaccharide, and by modulating the inflammatory response to infection. Category A biological agents and materials, as classified by the United States National Institutes for Health, the US Centers for Disease Control and Prevention, and the US Department of Homeland Security, carry the most severe threat in terms of human health, transmissibility, and preparedness. As such, there is a pressing need for novel frontline approaches for prevention and treatment of diseases caused by these organisms, and exploiting the broad antimicrobial activity exhibited by cationic host defense peptides represents an exciting priority area for clinical research. This review will summarize what is known about the antimicrobial and antiviral effects of the two main families of cationic host defense peptides, cathelicidins, and defensins in the context of Category A biological agents which include, but are not limited to; anthrax (Bacillus anthracis), plague (Yersinia pestis), smallpox (Variola major), tularemia (Francisella tularensis). In addition, we highlight priority areas, particularly emerging viral infections, where more extensive research is urgently required.


Subject(s)
Anti-Infective Agents/therapeutic use , Antimicrobial Cationic Peptides/therapeutic use , Antiviral Agents/therapeutic use , Communicable Diseases, Emerging/drug therapy , Cathelicidins/therapeutic use , Defensins/therapeutic use , Humans
4.
Toxicol In Vitro ; 29(7): 1513-28, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26086123

ABSTRACT

The potential toxicity of carbon nanotubes (CNTs) has been compared to pathogenic fibres such as asbestos. It is important to test this hypothesis to ascertain safe methods for CNT production, handling and disposal. In this study aspects reported to contribute to CNT toxicity were assessed: length, aspect ratio, iron content and crystallinity; with responses compared to industrially produced MWCNTs and toxicologically relevant materials such as asbestos. The impacts of these particles on a range of macrophage models in vitro were assessed due to the key role of macrophages in particle clearance and particle/fibre-induced disease. Industrially produced and long MWCNTs were cytotoxic to cells, and were potent in inducing pro-inflammatory and pro-fibrotic immune responses. Short CNTs did not induce any cytotoxicity. Frustrated phagocytosis was most evident in response to long CNTs, as was respiratory burst and reduction in phagocytic ability. Short CNTs, metal content and crystallinity had less or no influence on these endpoints, suggesting that many responses were fibre-length dependent. This study demonstrates that CNTs are potentially pathogenic, as they were routinely found to induce detrimental responses in macrophages greater than those induced by asbestos at the same mass-based dose.


Subject(s)
Macrophages/drug effects , Nanotubes, Carbon/toxicity , Animals , Asbestos, Amosite/toxicity , Bronchoalveolar Lavage Fluid/cytology , Cell Line , Cell Survival/drug effects , Cells, Cultured , Chemokine CCL2/metabolism , Humans , Iron/analysis , Macrophages/metabolism , Macrophages/physiology , Male , Mice , Nanotubes, Carbon/chemistry , Particle Size , Phagocytosis/drug effects , Rats, Sprague-Dawley , Soot/toxicity , Transforming Growth Factor beta1/metabolism , Tumor Necrosis Factor-alpha/metabolism
5.
Toxicol Appl Pharmacol ; 266(1): 19-26, 2013 Jan 01.
Article in English | MEDLINE | ID: mdl-23142470

ABSTRACT

Zinc oxide (ZnO) particle induced cytotoxicity was dependent on size, charge and solubility, factors which at sublethal concentrations may influence the activation of the human monocytic cell line THP1. ZnO nanoparticles (NP; average diameter 70nm) were more toxic than the bulk form (<44µm mesh) and a positive charge enhanced cytotoxicity of the NP despite their relatively high dissolution. A positive charge of the particles has been shown in other studies to have an influence on cell viability. Centrifugal filtration using a cut off of 5kDa and Zn element analysis by atomic absorption spectroscopy confirmed that exposure of the ZnO particles and NP to 10% foetal bovine serum resulted in a strong association of the Zn(2+) ion with protein. This association with protein may influence interaction of the ZnO particles and NP with THP1 cells. After 24h exposure to the ZnO particles and NP at sublethal concentrations there was little effect on immunological markers of inflammation such as HLA DR and CD14, although they may induce a modest increase in the adhesion molecule CD11b. The cytokine TNFα is normally associated with proinflammatory immune responses but was not induced by the ZnO particles and NP. There was also no effect on LPS stimulated TNFα production. These results suggest that ZnO particles and NP do not have a classical proinflammatory effect on THP1 cells.


Subject(s)
Monocytes/metabolism , Nanoparticles/administration & dosage , Nanoparticles/chemistry , Particle Size , Zinc Oxide/chemistry , Zinc Oxide/pharmacology , Humans , Monocytes/drug effects , Solubility/drug effects
6.
Toxicol Appl Pharmacol ; 232(3): 418-27, 2008 Nov 01.
Article in English | MEDLINE | ID: mdl-18708083

ABSTRACT

This study investigated the uptake, kinetics and cellular distribution of different surface coated quantum dots (QDs) before relating this to their toxicity. J774.A1 cells were treated with organic, COOH and NH2 (PEG) surface coated QDs (40 nM). Model 20 nm and 200 nm COOH-modified coated polystyrene beads (PBs) were also examined (50 microg ml(-1)). The potential for uptake of QDs was examined by both fixed and live cell confocal microscopy as well as by flow cytometry over 2 h. Both the COOH 20 nm and 200 nm PBs were clearly and rapidly taken up by the J774.A1 cells, with uptake of 20 nm PBs being relatively quicker and more extensive. Similarly, COOH QDs were clearly taken up by the macrophages. Uptake of NH2 (PEG) QDs was not detectable by live cell imaging however, was observed following 3D reconstruction of fixed cells, as well as by flow cytometry. Cells treated with organic QDs, monitored by live cell imaging, showed only a small amount of uptake in a relatively small number of cells. This uptake was insufficient to be detected by flow cytometry. Imaging of fixed cells was not possible due to a loss in cell integrity related to cytotoxicity. A significant reduction (p<0.05) in the fluorescent intensity in a cell-free environment was found with organic QDs, NH2 (PEG) QDs, 20 nm and 200 nm PBs at pH 4.0 (indicative of an endosome) after 2 h, suggesting reduced stability. No evidence of exocytosis was found over 2 h. These findings confirm that surface coating has a significant influence on the mode of NP interaction with cells, as well as the subsequent consequences of that interaction.


Subject(s)
Quantum Dots , Animals , Cell Line, Tumor , Exocytosis , Flow Cytometry , Fluorescence , Hydrogen-Ion Concentration , Macrophages/drug effects , Macrophages/metabolism , Mice , Microscopy, Confocal , Nanoparticles/chemistry , Nanoparticles/toxicity , Particle Size , Polystyrenes/chemistry
8.
Inhal Toxicol ; 16(9): 607-13, 2004 Aug.
Article in English | MEDLINE | ID: mdl-16036753

ABSTRACT

C-reactive protein (CRP) is the prototypic human acute-phase protein and is found at increased levels in the blood during episodes of inflammation. CRP was generally thought to be produced only by hepatocytes; however, several studies have shown extrahepatic synthesis of CRP. A previous study showed that PM10 and ultrafine carbon black (ufCB) were able to induce CRP expression in A549 cells. This study aims to examine the factors that lead to the production of CRP in A549 cells. A549 human lung epithelial cells were treated with cytokines (interleukin 6, tumor necrosis factor alpha, interferon gamma, or interleukin 1beta) or carbon particles (CB and ufCB) for 18 h. It was found that CRP could be expressed within the cells and that CRP was secreted from the cells particularly with tumor necrosis factor alpha, CB and ufCB treatments. It was also found that this expression of CRP with CB and ufCB treatments was dependent on nuclear factor kappa B (NFkappaB). The expression of CRP in A549 cells may indicate an important role for CRP expression and secretion from lung epithelial cells in response to inflammatory stimuli.


Subject(s)
C-Reactive Protein/metabolism , Carbon/toxicity , Cytokines/pharmacology , Lung/metabolism , Up-Regulation/physiology , Brefeldin A/pharmacology , Cell Line, Tumor , Enzyme-Linked Immunosorbent Assay , Epithelial Cells/metabolism , Fluorescent Antibody Technique , Humans , Lung/cytology , NF-kappa B/metabolism , Protein Synthesis Inhibitors/pharmacology , RNA, Messenger/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction
9.
Parasite Immunol ; 24(1): 15-22, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11856442

ABSTRACT

Migration of L3 larvae of Nippostrongylus brasiliensis through the lungs of the rat, during primary infection, was studied at 24 h, 72 h and 8 days. At 24 h p.i., there was evidence of damage to lung epithelial cells and microvasculature, with increased protein and gamma-glutamyl transpeptidase in the bronchoalveolar lavage (BAL) fluid. However, there was little evidence of inflammatory cell recruitment. At 24 h p.i., there was a significant reduction in the inflammatory cytokine tumour necrosis factor alpha. Superoxide (O2-*) production was also reduced, accompanied by an increase in superoxide dismutase activity. Lipid peroxidation was reduced at 24 h p.i. and L3 larvae were shown to possess high levels of glutathione compared to host lung tissue. Nitric oxide, detected as nitrite, was produced in BAL fluid, and inducible nitric oxide synthase protein was increased by 72 h p.i. There was evidence of peroxynitrite production throughout the infection period with specific protein bands nitrosylated at 75, 30 and 25 kDa. It appears that despite early evidence of lung damage, the inflammation was reduced in response to L3 larvae of N. brasiliensis.


Subject(s)
Nippostrongylus/pathogenicity , Nitric Oxide/metabolism , Oxidative Stress , Pneumonia/physiopathology , Strongylida Infections/physiopathology , Animals , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , Female , Lung/parasitology , Lung/pathology , Male , Nippostrongylus/growth & development , Nippostrongylus/physiology , Pneumonia/immunology , Pneumonia/parasitology , Pneumonia/pathology , Rats , Rats, Wistar , Strongylida Infections/immunology , Strongylida Infections/parasitology , Strongylida Infections/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...